Logo for OnKure Therapeutics Inc

OnKure Therapeutics Investor Relations Material

Latest events

Logo for OnKure Therapeutics

Q1 2025

6 May, 2025
Logo for OnKure Therapeutics

Q4 2024

11 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from OnKure Therapeutics Inc

Access all reports
Reneo Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing therapies for patients with rare genetic mitochondrial diseases. These diseases often involve the mitochondria's inability to efficiently produce energy for cells, impacting various bodily functions. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.